A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...

As the Trump administration issued an abrupt pause to federal financial assistance, the move threatened billions in grants ...

President Trump has placed an indefinite suspension on research grant reviews and travel at the National Institutes of Health ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

A trio of Democrats on Monday called on the Trump administration to restore full operations at the National Institutes of ...

Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...

Cancellations of NIH grant review panels, in particular, could affect cancer research grants and funding. In these NIH grant ...

In a letter, three Maryland Democrats said they had "grave concerns" that Trump's move would do lasting damage ...

Scientists at the National Institutes of Health have been told the communications pause announced by the Trump Administration ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to ...

Salt Lake City-based pharmaceutical company Clene Inc. has amended its grant subaward with Columbia University, securing up ...

Pharmaron, a Chinese biotech firm, is currently using hundreds of thousands of taxpayer dollars to test pharmaceuticals on up ...